Covered recipient · General Payments record
MARK D RICKMEYER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,885.04
- Reported across 165 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $386.91 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $221.15 | 12 |
| Amgen Inc. | $31.56 | 2 |
| Novo Nordisk AS | $28.40 | 2 |
| PFIZER INC. | $21.40 | 1 |
| Lilly USA, LLC | $20.08 | 1 |
| Janssen Pharmaceuticals, Inc | $19.00 | 1 |
| Acerta Pharma LLC | $15.87 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.91 | 1 |
| GlaxoSmithKline, LLC. | $14.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.31 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947398 | CMS |
| ABBVIE INC. | $27.86 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947400 | CMS |
| ABBVIE INC. | $7.93 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947402 | CMS |
| ABBVIE INC. | $13.01 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947404 | CMS |
| ABBVIE INC. | $4.86 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947406 | CMS |
| ABBVIE INC. | $27.64 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947408 | CMS |
| ABBVIE INC. | $32.41 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947410 | CMS |
| ABBVIE INC. | $17.22 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947412 | CMS |
| ABBVIE INC. | $7.14 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947414 | CMS |
| ABBVIE INC. | $12.87 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947416 | CMS |
| ABBVIE INC. | $27.35 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947418 | CMS |
| ABBVIE INC. | $25.55 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105947420 | CMS |
| Amgen Inc. | $13.94 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117364629 | CMS |
| Amgen Inc. | $17.62 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111688146 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.87 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105756695 | CMS |
| GlaxoSmithKline, LLC. | $14.54 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115744066 | CMS |
| Janssen Pharmaceuticals, Inc | $19.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078057686 | CMS |
| Lilly USA, LLC | $20.08 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135162527 | CMS |
| Novo Nordisk Inc | $14.99 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096858073 | CMS |
| Novo Nordisk Inc | $13.41 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096797785 | CMS |
| PFIZER INC. | $21.40 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131722032 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.91 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153555815 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.